1 / 1

Promising Treatment Response: pS6 and SUVmax Reduction in Perihepatic Disease

This study highlights a significant 56% reduction in pS6 staining and a 30% decrease in SUVmax in perihepatic disease following treatment. Promising CA125 response was also observed. These findings suggest a potential effective treatment approach for this condition.

oliver-russell
Download Presentation

Promising Treatment Response: pS6 and SUVmax Reduction in Perihepatic Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A Baseline On-treatment 56% decrease in pS6 staining B C 30% decrease SUVmax in perihepatic disease CA125 Response Observed

More Related